Vosevi 400 mg/1
SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR · TABLET, FILM COATED · Gilead Sciences, Inc.
Vosevi is an oral prescription tablet used to treat hepatitis C virus infection. It contains three active ingredients that work together as antiviral agents to stop the virus from replicating.
Key Facts
- Brand Name
- Vosevi
- Generic Name
- SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR
- NDC Code (Product)
61958-2401- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 400 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA209195
- Drug Class
- Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]; Hepatitis C Virus NS5A Inhibitor [EPC]
- Marketing Start
- 07/18/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is Vosevi used for?
Vosevi is an oral prescription tablet used to treat hepatitis C virus infection. It contains three active ingredients that work together as antiviral agents to stop the virus from replicating.
Is Vosevi a controlled substance?
Vosevi is not classified as a controlled substance by the DEA.
What is the generic name for Vosevi?
The generic name for Vosevi is SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR. There are no other listed brand versions of SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR.
What is the NDC code for Vosevi 400 mg/1?
The NDC (National Drug Code) for Vosevi 400 mg/1 is 61958-2401, listed by Gilead Sciences, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)